Literature DB >> 4322071

The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.

W L Dewey, T C Peng, L S Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4322071     DOI: 10.1016/0014-2999(70)90094-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Addict Rep       Date:  2014-06-01

2.  Effect of acute administration of delta 1-tetrahydrocannabinol on beta-endorphin levels in plasma and brain tissue of the rat.

Authors:  V M Wiegant; C G Sweep; I Nir
Journal:  Experientia       Date:  1987-04-15

3.  Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring.

Authors:  L L Murphy; J Gher; A Szary
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

Review 4.  The effects of cannabis and cannabinoids on the endocrine system.

Authors:  Farah Meah; Michelle Lundholm; Nicholas Emanuele; Hafsa Amjed; Caroline Poku; Lily Agrawal; Mary Ann Emanuele
Journal:  Rev Endocr Metab Disord       Date:  2021-08-30       Impact factor: 9.306

5.  Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

6.  Corticotrophin and corticosterone secretion following delta 1-Tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats.

Authors:  M Puder; J Weidenfeld; I Chowers; I Nir; N Conforti; R A Siegel
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

Review 7.  Critical appraisal of the potential use of cannabinoids in cancer management.

Authors:  Belinda J Cridge; Rhonda J Rosengren
Journal:  Cancer Manag Res       Date:  2013-08-30       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.